Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLANI in Opioid Dependent Persons Receiving Repeat Dosing
NCT05382091Phase 2Not yet recruiting
- Sponsor
- Go Medical Industries
- Start
- Jan 2027
- Primary completion
- Jul 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by Go Medical Industries. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05382091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05382091.